Aristotle Capital Boston, LLC
-0.91%
3个月收益率
$39.190
-0.247 (-0.63%)收盘时
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.
Guardian Pharmacy Services Inc is a good buy right now, trading at $39.44, which is significantly below the analyst consensus target of $49.81. The stock has shown strong growth, with a year-to-date change of +33.56% and a 1-year change of +35.77%. The forward P/E ratio of 30.21 suggests reasonable growth expectations, while the gross margin has improved to 22.75%. However, the RSI is at 42.11, indicating it is nearing oversold territory, which could present a buying opportunity.

Keybanc Initiates Coverage of Guardian Pharmacy Services with Overweight Rating

Latest Wall Street Ratings Overview

Guardian Pharmacy Acquires Nautilus Pharmacy Assets to Enhance LTC Services

Guardian Pharmacy Services to Participate in Jefferies Healthcare Conference

Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.
Guardian Pharmacy Services Inc is a good buy right now, trading at $39.44, which is significantly below the analyst consensus target of $49.81. The stock has shown strong growth, with a year-to-date change of +33.56% and a 1-year change of +35.77%. The forward P/E ratio of 30.21 suggests reasonable growth expectations, while the gross margin has improved to 22.75%. However, the RSI is at 42.11, indicating it is nearing oversold territory, which could present a buying opportunity.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。